SightfileU.S. market data from official filings

Companies › LNAI

Lunai Bioworks Inc (LNAI)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001527728 · EDGAR filings · Updated 2026-07-17

Lunai Bioworks Inc (LNAI) has reported institutional ownership of 2.7%, with 28 institutional managers holding positions valued at $403.0K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
2.7%
Institutional managers
28
Reported 13F value
$403.0K
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Lunai Bioworks Inc has 28 institutional holders and institutional ownership of 2.7%.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2023-02-27) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-05-11 (recurring since 2022-10-21) — source filing. The authoritative details are those stated in the filing itself.

Related companies

ENDRA LIFE SCIENCES INC (NDRA) · POLYRIZON LTD (PLRZ) · Scienture Holdings Inc (SCNX) · PMGC HLDGS INC (ELAB) · Theriva Biologics Inc (TOVX) · SILO PHARMA INC (SILO)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.